1887

Journal of General Virology header logo

Volume 85, Issue 7

Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants Free

Abstract

Vaccines produced in transgenic plants constitute a promising alternative to conventional immunogens, presenting the possibility of stimulating secretory and systemic immunity against enteric pathogens when administered orally. Protection against enteric pathogens affecting newborn animals requires, in most cases, the stimulation of lactogenic immunity. Here, the group presents the development of an experimental immunogen based on expression of an immunorelevant peptide, eBRV4, of the VP4 protein of bovine rotavirus (BRV), which has been described as harbouring at least one neutralizing epitope as well as being responsible for the adsorption of the virus to epithelial cells. The eBRV4 epitope was efficiently expressed in transgenic alfalfa as a translational fusion protein with the highly stable reporter enzyme -glucuronidase (GUS), which served as a carrier, stabilized the synthesized peptide and facilitated screening for the higher expression levels in plants. Correlation of expression of the eBRV4 epitope in plants with those presenting the highest GUS activities was confirmed by a Western blot assay specific for the BRV peptide. The eBRV4 epitope expressed in plants was effective in inducing an anti-rotavirus antibody response in adult female mice when administered either intraperitoneally or orally and, more importantly, suckling mice born from immunized female mice were protected against oral challenge with virulent rotavirus. These results demonstrate the feasibility of inducing lactogenic immunity against an enteric pathogen using an edible vaccine produced in transgenic plants.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19659-0
2004-07-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/7/vir851825.html?itemId=/content/journal/jgv/10.1099/vir.0.19659-0&mimeType=html&fmt=ahah

References

  1. Al-Yousif Y., Al-Majhdi F., Chard-Bergstrom C., Anderson J., Kapil S. 2000; Development, characterization, and diagnostic applications of monoclonal antibodies against bovine rotavirus. Clin Diagn Lab Immunol 7:288–292
     [Google Scholar]
  2. Arakawa T., Chong D. K. X., Langridge W. H. R. 1998; Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat Biotechnol 16:292–297 [CrossRef]
     [Google Scholar]
  3. Carrillo C., Wigdorovitz A., Oliveros J. C., Zamorano P. I., Sadir A. M., Gómez N., Salinas J., Escribano J. M., Borca M. V. 1998; Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. J Virol 72:1688–1690
     [Google Scholar]
  4. Carrillo C., Wigdorovitz A., Trono K., Dus Santos M. J., Castañón S., Sadir A. M., Odas R., Escribano J. M., Borca M. V. 2001; Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants. Viral Immunol 14:49–57 [CrossRef]
     [Google Scholar]
  5. Castañón S., Marín M. S., Martín Alonso J. M., Boga J. A., Casais R., Humara J. M., Ordas R. J., Parra F. 1999; Immunization with potato plants expressing VP60 proteins protects against rabbit hemorragic disease virus. J Virol 73:4452–4455
     [Google Scholar]
  6. Chiapello H., Lisacek F., Caboche M., Henaut A. 1998; Codon usage and gene function are related in sequences of Arabidopsis thaliana . Gene 209:GC1–GC38 [CrossRef]
     [Google Scholar]
  7. Dus Santos M. J., Wigdorovitz A., Trono K. 7 other authors 2002; A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine 20:1141–1147 [CrossRef]
     [Google Scholar]
  8. Fernandez F. M., Conner M. E., Parwani A. V., Todhunter D., Smith K. L., Crawford S. E., Estes M. K., Saif L. J. 1996; Isotype-specific antibody responses to rotavirus and virus proteins in cows inoculated with subunit vaccines composed of recombinant SA11 rotavirus core-like particles (CLP) or virus-like particles (VLP). Vaccine 14:1303–1312 [CrossRef]
     [Google Scholar]
  9. Gil F., Brun A., Wigdorovitz A., Catala R., Martinez-Torrecuadrada J. L., Casal I., Salinas J., Borca M. V., Escribano J. M. 2001; High-yield expression of a viral peptide vaccine in transgenic plants. FEBS Lett 488:13–17 [CrossRef]
     [Google Scholar]
  10. Gómez N., Carrillo C., Parra F., Salinas J., Borca M. V., Escribano J. M. 1998; Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants. Virology 249:352–358 [CrossRef]
     [Google Scholar]
  11. Gómez N., Wigdorovitz A., Castañón A., Gil F., Ordas R., Borca M. V., Escribano J. M. 2000; Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus. Arch Virol 145:1725–1732 [CrossRef]
     [Google Scholar]
  12. Haq T. A., Mason H. S., Clements J. D., Arntzen C. J. 1995; Oral immunization with recombinant bacterial antigen produced in transgenic plants. Science 268:714–716 [CrossRef]
     [Google Scholar]
  13. Ijaz M. K., Sabara M. I., Frenchick P. J., Babiuk L. A. 1987; Effect of different routes of immunization with bovine rotavirus on lactogenic antibody response in mice. Antiviral Res 8:283–297 [CrossRef]
     [Google Scholar]
  14. Ijaz M. K., Attah-Poku S. K., Redmond M. J., Parker M. D., Sabara M. I., Frenchick P., Babiuk L. A. 1991; Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus. J Virol 65:3106–3113
     [Google Scholar]
  15. Ijaz M. K., Alkarmi T. O., Sabara M. I. 7 other authors 1995; Characterization of a synthetic peptide mimicking trypsin-cleavage site of rotavirus VP4. Comp Immunol Microbiol Infect Dis 18:145–160 [CrossRef]
     [Google Scholar]
  16. Ijaz M. K., Nur-e-Kamal M. S., Dar F. K., Uduman S., Redmond M. J., Attah-Poku S. K., Dent D., Babiuk L. A. 1998; Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4. Vaccine 16:916–920 [CrossRef]
     [Google Scholar]
  17. Kapikian A., Chanock R. 1996; Rotaviruses. In Fields Virology . , 3rd edn. pp  1657–1708 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
  18. Kim Y., Nielsen P. R., Hodgings D., Chang K. O., Saif L. J. 2002; Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines. Vaccine 20:1248–1258 [CrossRef]
     [Google Scholar]
  19. Lee J., Babiuk L. A., Harland R., Gibbons E., Elazhary Y., Yoo D. 1995; Immunological response to recombinant VP8* subunit protein of bovine rotavirus in pregnant cattle. J Gen Virol 76:2477–2483 [CrossRef]
     [Google Scholar]
  20. Mason H. S., Lam D. M.-K., Arntzen C. J. 1992; Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci U S A 89:11745–11749 [CrossRef]
     [Google Scholar]
  21. Mason H. S., Ball J. M., Shi J. J., Jiang X., Estes M. K., Arntzen C. J. 1996; Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci U S A 93:5335–5340 [CrossRef]
     [Google Scholar]
  22. Mason H. S., Haq T. A., Clements J. D., Arntzen C. J. 1998; Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16:1336–1343 [CrossRef]
     [Google Scholar]
  23. McGarvey P. B., Hammond J., Dienelt M. M., Hooper D. C., Fu Z. F., Dietzschold B., Koprowski H., Michaels F. H. 1995; Expression of rabies virus glycoprotein in transgenic tomatoes. Biotechnology (N Y) 13:1484–1487 [CrossRef]
     [Google Scholar]
  24. McKersie B. D., Chen Y., de Beus M., Bowley S. R. 1993; Superoxide dismutase enhances tolerance of freezing stress in transgenic alfalfa. Plant Physiol 103:1155–1163 [CrossRef]
     [Google Scholar]
  25. Offit P. A., Clark H. F. 1985; Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody. J Infect Dis 152:1152–1158 [CrossRef]
     [Google Scholar]
  26. Offit P. A., Shaw R. D., Greenberg H. B. 1986; Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol 58:700–703
     [Google Scholar]
  27. Richter L. J., Thanavala Y., Arntzen C. J., Mason H. S. 2000; Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 18:1167–1171 [CrossRef]
     [Google Scholar]
  28. Ruggeri F. M., Greenberg H. B. 1991; Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol 65:2211–2219
     [Google Scholar]
  29. Saif L. J., Redman D. R., Smith K. L., Theil K. W. 1983; Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from immunized or nonimmunized cows. Infect Immun 41:1118–1131
     [Google Scholar]
  30. Shaw A. L., Rothnagel R., Chen D., Ramig R. F., Chiu W., Prasad B. V. 1993; Three-dimensional visualization of the rotavirus hemagglutinin structure. Cell 74:693–701 [CrossRef]
     [Google Scholar]
  31. Shen W. J., Forde B. G. 1989; Efficient transformation of Agrobacterium spp. by high voltage electroporation. Nucleic Acids Res 17:8385 [CrossRef]
     [Google Scholar]
  32. Shetty K., McKersie B. D. 1993; Proline, thioproline and potassium mediated stimulation of somatic embryogenesis in alfalfa. Plant Sci 88:185–193 [CrossRef]
     [Google Scholar]
  33. Wigdorovitz A., Carrillo C., Dus Santos M. J., Sadir A. M., Rios R., Franzione P., Escribano J. M., Borca M. V. 1999; Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255:347–353 [CrossRef]
     [Google Scholar]
  34. Yu J., Langridge W. H. 2001; A plant-based multicomponent vaccine protects mice from enteric diseases. Nat Biotechnol 19:548–552 [CrossRef]
     [Google Scholar]
  35. Yuan L., Geyer A., Saif L. J. 2001; Short-term immunoglobulin A B-cell memory resides in intestinal lymphoid tissues but not in bone marrow of gnotobiotic pigs inoculated with Wa human rotavirus. Immunology 103:98–108 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19659-0
Loading
Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants
J. Gen. Virol. 85, 1825 (2004); https://doi.org/10.1099/vir.0.19659-0
/content/journal/jgv/10.1099/vir.0.19659-0
/content/journal/jgv/10.1099/vir.0.19659-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error